Mineralys Therapeutics, Inc. MLYS

Set alert

15.33 USD +0.09 (+0.59%)

At closeNov 6, 2026, 4:00 PM EST

15.33 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

14.95 Day range 15.65

14.95 52-week range 47.65

Held by insiders 0.73%

Held by institutions 116.44%

Float held by institutions 117.29%

Institutions 324

Top institutional holders
Holder	% held	Shares	Value	Reported
Catalys Pacific, LLC	8.81%	7,799,518	119.57M	Sep 29, 2026
RA Capital Management, L.P.	8.69%	7,692,750	117.93M	Jun 29, 2026
Blackrock Inc.	6.65%	5,887,038	90.25M	Jun 29, 2026
Samsara BioCapital, LLC	6.63%	5,871,018	90.00M	Jun 29, 2026
FMR, LLC	5.09%	4,511,689	69.16M	Jun 29, 2026
State Street Corporation	4.68%	4,141,636	63.49M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SmallCap World Fund Inc	2.83%	2,502,854	38.37M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.22%	1,968,124	30.17M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	1.79%	1,584,493	24.29M	Sep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.66%	1,468,689	22.52M	Sep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio	1.33%	1,180,000	18.09M	Sep 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund	1.09%	962,999	14.76M	Sep 29, 2026

MLYS insiders
Insider	Relation	Latest transaction	Date	Shares held
AKKARAJU SRINIVAS	Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant)	Feb 18, 2026	5,877,220
CONGLETON JON	Chief Executive Officer	Sale	Jul 12, 2026	603,621
FERGUSON JAMES J. III	Officer	Stock Award(Grant)	Aug 9, 2026	102,400
KARYDAS DAPHNE	Director	Sale	Sep 14, 2026	6,200
LEVY ADAM SCOTT	Chief Financial Officer	Stock Award(Grant)	Feb 18, 2026	48,538
RA CAPITAL MANAGEMENT, L.P.	Beneficial Owner of more than 10% of a Class of Security	Purchase	Mar 29, 2026	0

Held by funds